Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Voretigene Neparvovec-rzyl (Luxturnaâ¢)Article · A56401 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Lumbar Spinal FusionArticle · A56397 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | FDG PET for Soft Tissue Sarcoma (Replaced with Section 220.6.17) - RETIREDNCD · NCD303 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Cardiac Radionuclide ImagingLCD · L33457 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Transurethral Waterjet Ablation of the ProstateArticle · A59932 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | FDG PET for Thyroid Cancer (Replaced with Section 220.6.17) - RETIREDNCD · NCD302 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Opioid Treatment ProgramsLCD · L39849 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Endoscopic Treatment of GERDArticle · A56395 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Lumbar Spinal FusionArticle · A56396 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | FDG PET for Breast Cancer (Replaced with Section 220.6.17) - RETIREDNCD · NCD297 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | FDG PET for Refractory SeizuresNCD · NCD294 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Lumbar Artificial Disc ReplacementArticle · A56393 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Topical Oxygen TherapyArticle · A56392 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Lumbar Artificial Disc ReplacementArticle · A56390 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Upper Gastrointestinal Endoscopy and VisualizationArticle · A56389 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Supervised Exercise Therapy for the Treatment of Peripheral Arterial Disease with Symptomatic Lower Extremity Intermittent ClaudicationArticle · A56384 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Helicobacter Pylori Infection TestingArticle · A56382 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Helicobacter Pylori Infection TestingArticle · A56381 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: RituximabArticle · A56380 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic TestArticle · A56376 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic TestArticle · A56375 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung CancerArticle · A56374 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic TestArticle · A56366 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression TestArticle · A56357 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression TestArticle · A56356 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: MDS FISHArticle · A56354 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: MDS FISHArticle · A56329 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic TestArticle · A56315 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)Article · A56313 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression TestArticle · A56283 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Chiropractic ServicesArticle · A56273 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression TestArticle · A56272 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)Article · A56257 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)Article · A56256 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential TremorArticle · A56254 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential TremorArticle · A56253 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Frequency of HemodialysisArticle · A56241 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid DiseasesArticle · A59898 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: DecisionDx-MelanomaArticle · A56231 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: DecisionDx-MelanomaArticle · A56230 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Frequency of HemodialysisArticle · A56215 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Cystatin C MeasurementArticle · A56211 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs)Article · A56190 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Cystatin C MeasurementArticle · A56177 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral PanelsArticle · A56161 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Frequency of HemodialysisArticle · A56159 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Pulmonary Rehabilitation ServicesArticle · A56152 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)Article · A56148 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Corus® CAD AssayArticle · A56142 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: ChemotherapyArticle · A56141 | Metadata changed |
|---|